Overall, the incidence of colorectal cancer has decreased over the decades, largely in part due to the use of screening ...

To better predict these risks, the new guidelines recommend that all stage 2 and 3 colorectal tumors undergo molecular ...

According to the American Cancer Society, colorectal cancer is one of the leading causes of cancer in men and women.

Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...

With March being colon cancer awareness month, it’s a good time to look at some startling numbers on the disease here in the ...

With March being National Colorectal Cancer Awareness Month, there’s never been a better time to screen for the disease. CRC ...

Colorectal cancer—often called colon cancer—is the fourth most commonly diagnosed cancer and the second deadliest cancer in the United States, according to the Colorectal Cancer Alliance.

The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...

Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...

Cologuard and other at-home tests are not intended for and have not been tested in people with Lynch syndrome. Furthermore, ...

The Shield Across America Tour is in Nashville offering a non-invasive, FDA-approved blood test for colorectal cancer ...

A sharp rise in colorectal cancer cases among young adults has made the disease the leading cause of cancer death for people ...